4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

BRYJA, Vítězslav, Pavlína JANOVSKÁ, Michaela GREGOROVÁ, Václav NĚMEC, PrashantKumar KHIRSARIYA and Kamil PARUCH. 4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors. 2021.

Basic information

• Original name: 4—(1h— imidazol— 5— yl) -1h-pyrrolo (2, 3-b) pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
• Authors: BRYJA, Vítězslav (203 Czech Republic, belonging to the institution), Pavlína JANOVSKÁ (203 Czech Republic, belonging to the institution), Michaela GREGOROVÁ (203 Czech Republic, belonging to the institution), Václav NĚMEC (203 Czech Republic, belonging to the institution), PrashantKumar KHIRSARIYA (356 India, belonging to the institution) and Kamil PARUCH (203 Czech Republic, belonging to the institution).
• Edition: Number: AU 2019246220, Publisher: The Australian Patents Register, Place of publication: Australia, Owner's name: Masarykova univerzita, 2021.

Other information

• Original language: English
• Type of outcome: Patent
• Field of Study: 10401 Organic chemistry
• Country of publisher: Australia
• Confidentiality degree: is not subject to a state or trade secret
• WWW: URL
• RIV identification code: RIV/00216224:14310/21:00121220
• Organization unit: Faculty of Science
• Keywords in English: lymphomas; leukaemia; solid tumors

Abstract

The present invention relates to novel heterocyclic compounds useful in the treatment of leukaemias, lymphomas and solid tumors.

Links

• EF16_025/0007381, research and development project: Name: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou
• LM2018130, research and development project: Name: Národní infrastruktura chemické biologie (Acronym: CZ-­OPENSCREEN)

Investor: Ministry of Education, Youth and Sports of the CR